Scientific References Ozempic 1 mg solution for injection in pre-filled pen Summary of Product Characteristics
the highest dose of GSBR-1290 led to an average weight reduction of more than 8% from baseline within one week
Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al
William van Houtum: No conflict of interest
Every medication, including Ozempic and Adderall, has contraindications
2 Key Players In The GLP-1 Market Novo Nordisk Positioning: Novo Nordisk (Novo) is the undisputed leader in the GLP-1 receptor agonist market, largely due to the success of semaglutide, which is marketed as Ozempic for diabetes and Wegovy for weight management